NON VIRAL VECTORS FORM

Brand Owner (click to sort) Address Description
GENECAPS Calimmune, Inc. 35 N. Lake Avenue Pasadena CA 93551 Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system;GENE CAPS;
GENECAPS CSL BEHRING GENE THERAPY, INC. 35 N. Lake Avenue, Suite 650 Pasadena CA 91101 Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system; Non-viral vectors, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;GENE CAPS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to genetically engineered recombinant respiratory syncytial viruses and viral vectors which contain deletions of various viral accessory gene(s) either singly or in combination. In accordance with the present invention, the recombinant respiratory syncytial viral vectors and viruses are engineered to contain complete deletions of the M2-2, NS1, NS2, or SH viral accessory genes or various combinations thereof. In addition, the present invention relates to the attenuation of respiratory syncytial virus by mutagenisis of the M2-1 gene.